Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Groot Kormelink

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Pharmaceutical Design|June 13, 2009
Mast cells as target in cancer therapyTom Groot Kormelink, Abulikemu Abudukelimu, Frank A Redegeld
Mayo Clinic Proceedings|October 6, 2012
Polyclonal immunoglobulin free light chain and chronic inflammationFrank A Redegeld, Marco Thio, Tom Groot Kormelink
Current Pharmaceutical Design|March 7, 2012
Immunobiology of antigen-specific immunoglobulin free light chains in chronic inflammatory diseasesTom Groot Kormelink, Philip W Askenase, Frank A Redegeld
Arthritis and Rheumatism|December 1, 2011
Immunoglobulin free light chain levels and rituximab response in rheumatoid arthritis: comment on the article by Sellam et alJanneke Tekstra, Joel van Roon, Tom Groot Kormelink, et al.
Frontiers in Immunology|October 22, 2021
Targeting DCs for Tolerance Induction: Don't Lose Sight of the NeutrophilsFlorianne M J Hafkamp, Tom Groot Kormelink, Esther C de Jong
Journal of Leukocyte Biology|June 24, 2017
Granulocytes as modulators of dendritic cell functionAnnelot Breedveld, Tom Groot Kormelink, Marjolein van Egmond, et al.
BMC Genomics|July 16, 2008
An in silico analysis of T-box regulated genes and T-box evolution in prokaryotes, with emphasis on prediction of substrate specificity of transportersMichiel Wels, Tom Groot Kormelink, Michiel Kleerebezem, et al.
International Journal of Molecular Sciences|August 5, 2020
Orally Administered Exosomes Suppress Mouse Delayed-Type Hypersensitivity by Delivering miRNA-150 to Antigen-Primed Macrophage APC Targeted by Exosome-Surface Anti-Peptide Antibody Light ChainsKatarzyna Nazimek, Krzysztof Bryniarski, Wlodzimierz Ptak, et al.
Seminars in Immunopathology|April 5, 2018
The role of extracellular vesicles when innate meets adaptiveTom Groot Kormelink, Sanne Mol, Esther C de Jong, et al.
Circulation Research|April 3, 2010
Effects of free immunoglobulin light chains on viral myocarditisAkira Matsumori, Miho Shimada, Xiao Jie, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|June 13, 2009
Mast cells as target in cancer therapyTom Groot Kormelink, Abulikemu Abudukelimu, Frank A Redegeld
Mayo Clinic Proceedings|October 6, 2012
Polyclonal immunoglobulin free light chain and chronic inflammationFrank A Redegeld, Marco Thio, Tom Groot Kormelink
Current Pharmaceutical Design|March 7, 2012
Immunobiology of antigen-specific immunoglobulin free light chains in chronic inflammatory diseasesTom Groot Kormelink, Philip W Askenase, Frank A Redegeld
Arthritis and Rheumatism|December 1, 2011
Immunoglobulin free light chain levels and rituximab response in rheumatoid arthritis: comment on the article by Sellam et alJanneke Tekstra, Joel van Roon, Tom Groot Kormelink, et al.
Frontiers in Immunology|October 22, 2021
Targeting DCs for Tolerance Induction: Don't Lose Sight of the NeutrophilsFlorianne M J Hafkamp, Tom Groot Kormelink, Esther C de Jong
Journal of Leukocyte Biology|June 24, 2017
Granulocytes as modulators of dendritic cell functionAnnelot Breedveld, Tom Groot Kormelink, Marjolein van Egmond, et al.
BMC Genomics|July 16, 2008
An in silico analysis of T-box regulated genes and T-box evolution in prokaryotes, with emphasis on prediction of substrate specificity of transportersMichiel Wels, Tom Groot Kormelink, Michiel Kleerebezem, et al.
International Journal of Molecular Sciences|August 5, 2020
Orally Administered Exosomes Suppress Mouse Delayed-Type Hypersensitivity by Delivering miRNA-150 to Antigen-Primed Macrophage APC Targeted by Exosome-Surface Anti-Peptide Antibody Light ChainsKatarzyna Nazimek, Krzysztof Bryniarski, Wlodzimierz Ptak, et al.
Seminars in Immunopathology|April 5, 2018
The role of extracellular vesicles when innate meets adaptiveTom Groot Kormelink, Sanne Mol, Esther C de Jong, et al.
Circulation Research|April 3, 2010
Effects of free immunoglobulin light chains on viral myocarditisAkira Matsumori, Miho Shimada, Xiao Jie, et al.
Pageof 4